Teva, finally, names CEO

Teva Pharmaceutical Industries Ltd., after a lengthy search, named K åre Schultz as the generic drug company's new president and CEO. Schultz will succeed Dr. Yitzhak Peterburg, who will continue to serve as interim-CEO until Schultz, who will be relocating to the company's headquarters in Israel, starts. A nearly 30-year veteran of the pharmaceutical industry, Sc hultz most recently served as the president and CEO of H. Lundbeck A/S. Prior to that, he chief operating officer of Novo Nordis. He…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news